In a mouse model of post-myocardial infarction HF, it was found that treatment with the selective serotonin reuptake inhibitor paroxetine may inhibit GRK2 and promote βAR-mediated cardiomyocyte contractility [40]. This evidence concerns the gene GRK2 and myocardial infarction.